Andreessen Horowitz February 14, 2023
by Jorge Conde and Jay Rughani

Eroom’s Law (the backwards Moore) is the often cited, and arguably inaccurate, observation that drug discovery gets slower and more expensive over time. It’s certainly a slog, but R&D efforts have yielded 378 new FDA-approved drugs between 2010 and 2019, almost double the previous decade. As a metric, even FDA approvals underemphasize the astounding advances that come from biotech innovation–like printing a COVID vaccine in 48 hours that has reached billions.

When the term “biotech” entered the mainstream in the 1970s, the then-referenced “tech” was recombinant DNA, a technique to splice genes from one organism to another. Cohen and Boyer used this approach at their fledgling startup Genentech to coax bacteria to pump out human insulin; it helped birth an...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Cloud, Investments, Pharma / Biotech, Technology, Trends
4 top healthcare CIOs: Forbes
Trace Neuroscience Nets $101M in Series A Funding for ALS, Dementia Therapy Development
53% of US adults are eligible for Ozempic, Wegovy: Study
The Athlete's Edge: How One Biotech Startup Is Mining Elite Athletes' Gut Bacteria To Create Next-Gen Probiotics
Eli Lilly drug cuts genetic form of cholesterol by 86%: Study

Share This Article